Global Drug Abuse Treatment Market Growth (Status and Outlook) 2025-2031
The global Drug Abuse Treatment market size is predicted to grow from US$ 20180 million in 2025 to US$ 30020 million in 2031; it is expected to grow at a CAGR of 6.8% from 2025 to 2031.
Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
North America is the largest Drug Abuse Treatment market with about 48% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy"s Laboratories, Teva Pharmaceutical, PLIVA (Odyssey) etc. Top 5 companies occupied about 14% market share.
LPI (LP Information)' newest research report, the “Drug Abuse Treatment Industry Forecast” looks at past sales and reviews total world Drug Abuse Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug Abuse Treatment sales for 2025 through 2031. With Drug Abuse Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Abuse Treatment industry.
This Insight Report provides a comprehensive analysis of the global Drug Abuse Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug Abuse Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Abuse Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Abuse Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Abuse Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Abuse Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Segmentation by Application:
Hospital & Clinics
Residential (non-hospital)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
PLIVA (Odyssey)
Please note: The report will take approximately 2 business days to prepare and deliver.